msc clinical biochemistry

39
MSc Clinical Biochemistry. Carbohydrate Metabolism.

Upload: ellie

Post on 24-Feb-2016

106 views

Category:

Documents


5 download

DESCRIPTION

MSc Clinical Biochemistry. Carbohydrate Metabolism. Plan For The Evening. History of Diabetes and some things you did n’t know.. Carbohydrate Physiology. Diabetes Mechanisms. Treatment. Complications. Some Worked Examples. It’s all Greek to Me!!!. Diabetes Mellitus Dia through - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: MSc  Clinical Biochemistry

MSc Clinical Biochemistry.

Carbohydrate Metabolism.

Page 2: MSc  Clinical Biochemistry

Plan For The Evening.

History of Diabetes and some things you did n’t know..

Carbohydrate Physiology.

Diabetes Mechanisms.

Treatment.

Complications.

Some Worked Examples.

Page 3: MSc  Clinical Biochemistry

It’s all Greek to Me!!!

Diabetes MellitusDia throughBetes to go.Mellitus honey

“Anyone got a sweet tooth?”

Page 4: MSc  Clinical Biochemistry

Not a New Disease….

www.diabetes.ca/about-diabetes/what/history/

Page 5: MSc  Clinical Biochemistry

Famous Folks.Below are just a handful of the celebrities, sportsmen, politicians and socialites who have diabetes yet have not let the condition hold them back from attaining their goals and dreams.

Showbusiness Andrew Lloyd Webber,Elizabeth Taylor,Halle Berry,Sharon Stone,Victor Garber, Vanessa Williams.

Athletes Ayden Byle, Chris Southwell, Steve Redgrave, Gary Mabbutt.

Musicians Damon Dash, Aretha Franklin,Randy Jackson, Nick Jonas.

Artists, Authors & Comedians Jimmy Tarbuck [Comedian]HG Wells [Author]

Page 6: MSc  Clinical Biochemistry

There are currently over 2.6 million people with diabetes in the UK and there are up to half a million people with diabetes who have the condition and don't know it.

Including both adults and children, we estimate that:

15 per cent of people with diabetes have Type 1 diabetes.85 per cent of people with diabetes have Type 2 diabetes.

From Diabetes.org.uk

Page 7: MSc  Clinical Biochemistry

Physiology.Glucose is the principle energy source for our body.

Most organs have alternatives.

Glucose and to lesser extent ketones are the only options for brain function because.

Can’t store significant glucose.Can’t synthesise glucose.Can’t metabolise other substrates.

Page 8: MSc  Clinical Biochemistry

Insulin.• • Peptide Hormone

• Produced by b cells in the Islets of Langerhans in the pancreas

• Starts as pro- insulin and is cleaved to produce C-Peptide and Insulin.

Page 9: MSc  Clinical Biochemistry

Glucagon.• Peptide Hormone• Produced by the a cells in the

Islets of Langerhans in the pancreas.

• Generally opposes action of insulin.

Page 10: MSc  Clinical Biochemistry
Page 11: MSc  Clinical Biochemistry
Page 12: MSc  Clinical Biochemistry

Normal Glucose Metabolism.

The gut as a result of hydrolysis or hepatic conversion of a variety of ingested carbohydrates.

Hepatic and some other glycogen stores (glycogenolysis)

New synthesis from precursors. Gluconeogenesis occurs in the liver 70-90%ish and kidneys 10-25% from glucogenic amino acids and from glycerol, lactate and pyruvate.

Page 13: MSc  Clinical Biochemistry

Mechanisms Preventing /Reversing Hypoglycaemia.

Adrenergic/ Sympathetic Response.Promotes glycogenolysis, gluconeogenesis and increased glucose output by the liver, reduces gluocse clearance by adipose and skeletal muscle. Promotes lipolysis to provide alternative fuel sources. Inhibits insulin secretion.

Counter-regulatory Hormones.Glucagon promotes glycogenolysis, glucosneogenis and thus increased glucose output from the liver. May increase hepatic ketone production.Cortisol promotes glycogenolysis, glucosneogenis and thus increased glucose output from the liver. reduces gluocse clearance by adipose and skeletal muscleGrowth Hormone promotes hepatic glycogenolysis and increased hepatic glucose output, promotes lipolysis.

Other mechanisms.Insulin secretion inhibitedFeelings of hunger promote eating.Hypoglycaemia per se stimulates hepatic glucose output

Page 14: MSc  Clinical Biochemistry

Energy Use.Glucose provides 40-60% of bodies fuel expenditure on standard Western Diet.

During high intensity exercise and 4-6 hours post prandial glucose is the most prominent energy source.

Glucose is also the most efficient source of energy

6 moles ATP per mole of Oxygen consumed.

Page 15: MSc  Clinical Biochemistry

Glucose Transport.

Page 16: MSc  Clinical Biochemistry

Glucose Cellular Uptake.

Glucose is hydrophilic and requires a transporter to help it through the cell membrane.

GLUTS potentially bidirectional. Glucose trapped in cells by phosphorylation mediated by hexokinase/glucokinase.

Glucose then used forAerobic use, anaerobic use, synthesis of other molecules i.e. ( glycerol and carbon skeletons of non-essential amino acids), or stored as glycogen.

Page 17: MSc  Clinical Biochemistry

The input of Insulin.

Insulin interacts with insulin receptors. The signal cascade that results from this leads to GLUT molecules migrating to the cell membrane.The insulin and their receptor molecules are subsequently internalised. Receptors are later recycled to the surface.It is thought that internalisation of insulin is important to convey growth and protein synthesis signals to the cell nucleus.Also important to remove insulin from the circuation.

Page 18: MSc  Clinical Biochemistry

Insulin and Growth Factors.Insulin also has a measure of growth promoting activity.

Insulin-like Growth Factors IGF-1 and IGF-2 are closely homologous to insulin and are weak agonists to insulin receptors. Their impact on glucose metabolism is possibly less significant. The role is more relevent as a cellular growth factorr.

Tumour related hypoglycaemia can be a result of IGF excess.

Page 19: MSc  Clinical Biochemistry

Diabetes Diagnosis. < 5.5 > 11.1

5.6 – 11.1

> 7.0 <5.6

5.6 – 6.9 To diagnose IGT in absence of IFG 2 hr glu < 7.8 2 hr glucose > 11.1

2 hr glucose 7.8 – 11.0

Diabetes Excluded

Random Glucose

Diabetes Excluded

Diabetes

Diabetes

Diabetes

Fasting Glucose

Oral GTT

IGT

No IGT

IFG

Page 20: MSc  Clinical Biochemistry
Page 21: MSc  Clinical Biochemistry

Type 15-10% of Diabetics.

Severe insulin deficiency resulting from autoimmune B cell destruction.

Absolute requirement for exogenous insulin to avoid rapid decline into cachexia, dehydration, ketoacidosis and death.

Pre Banting and Best very poor almost universially fatal prognosis.

Page 22: MSc  Clinical Biochemistry
Page 23: MSc  Clinical Biochemistry

Type 2Probably heterogeneous diagnosis of exclusion.

Usually a measure of insulin resistance with often an ultimate insulin deficiency.

Some patients initially misdiagnosed may have LADA.

Usually present with obesity and increased BMI.

Some argue that insulin is often required to support oral and dietary control at a median 7 years post diagnosis.

Page 24: MSc  Clinical Biochemistry

Type 2 continued…

Leaner Type 2’s tend to be more insulin deficient, plumper Type 2’s tend to be more insulin resistant.

Controversial as to which mechanism predominates in Europe.

Secondary idiopathic causes may also “muddy the waters”

Inheritability a strong factor.

Page 25: MSc  Clinical Biochemistry

Progress From Resistance to

Deficiency

Page 26: MSc  Clinical Biochemistry

Secondary Causes to Consider.

Alcohol related

Haemochromatosis

Coeliac Disease

EndocrinePCOSSteroid Acromegaly

Insulin Antibodies (Historical.)

Page 27: MSc  Clinical Biochemistry

Diabetic Complications.

Microvascular.? Principally due to hyper glycaemia per se

Increased activation of the polyol pathway ultimately rendering cells vulnerable to oxidative stress.

Sorbitol found in cateracts, peripheral nerve damage and renal glomeruli.

Advanced glycation end products have also been implicated in structural changes leading to microvascular permeability.

Page 28: MSc  Clinical Biochemistry

Retinopathy.

Page 29: MSc  Clinical Biochemistry

Macrovascular.

Hypertension

Lipid abnormalities.More often a combination of low HDL, small dense LDL and hypertriglyceridaemia.

Page 30: MSc  Clinical Biochemistry

Treatment.Diet

Exercise

Smoking Cessation

Aspirin

Lipid lowering agents

ACE inhibitors et al.

Page 31: MSc  Clinical Biochemistry

DCCT and UKPDSMicrovascular and to some extent maybe macrovascular complications can be delayed or even prevented by tight glycaemic control.

Oral Hypoglycaemic “of choice” metformin reduces hepatic glucose output

Other options include sulphoylureas.

Page 32: MSc  Clinical Biochemistry

Diabetic Emergencies.

Page 33: MSc  Clinical Biochemistry

“Routine Diabetic Testing”

Glucose to diagnose and monitor

Microalbumin to assess early stage Diabetic Nephropathy.

Renal Function

Lipids.

HbA1c

Page 34: MSc  Clinical Biochemistry

HbA1c

Page 35: MSc  Clinical Biochemistry

HbA1c

Important ConsiderationsGlycation Rates.Assay variabilityStandardisationAssay FrequencyAnaemia.

Page 36: MSc  Clinical Biochemistry

HbA1c

Many people are advocating using HbA1c for diagnosis!

Discuss.

Page 37: MSc  Clinical Biochemistry

A Little Bit on Hypoglycaemia…..Acute Subacute ChronicSweating Reduction of spont

ActPersonality Changes

Anxiety Behavioural Change Defective memoryHunger Tiredness/

Somnelencedepression

NAUSEA Dizziness PsychosisTREMULOUSNESS Poor concentration dementiaWEAKNESS SeizuresPALPITATIONS ComaRESTLESSNESS

Page 38: MSc  Clinical Biochemistry

Investigation.

Page 39: MSc  Clinical Biochemistry

Hypos